Stay updated on Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial
Sign up to get notified when there's something new on the Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial page.

Latest updates to the Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial page
- ChecktodayChange DetectedRevision updated from v3.3.3 to v3.3.4; no study content or functionality changes were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedAdded Beijing Municipality under Locations and updated the location labeling; added Snyder et al. 2014 NEJM citation to Publications, while removing the previous Beijing Municipality Locations entry and its related Erratum citation.SummaryDifference0.3%

- Check50 days agoChange DetectedPublications section updated to clarify that publications are provided voluntarily by contributors who enter information about the study results, and the site revision badges were updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check58 days agoChange DetectedPublications section updated: a 2014 NEJM paper on CTLA-4 blockade was added with erratum details, and the previous citation entry was removed.SummaryDifference0.4%

- Check80 days agoChange DetectedThe two screenshots show the same Study Details page with identical trial information (title, conditions, eligibility criteria, interventions, outcomes, and locations). No core content or data elements were added or removed.SummaryDifference0.4%

- Check101 days agoChange Detected- Removed version v3.1.0 and added notice about government funding lapse and current NIH Clinical Center status with links, plus new version tag v3.2.0. The page now communicates operating status details and a newer software version.SummaryDifference2%

Stay in the know with updates to Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial page.